Syros Pharmaceuticals, Inc.
NASDAQ:SYRS
2.73 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0.386 | 3.762 | 2.833 | 2.954 | -5.467 | 3.891 | 6.276 | 5.467 | 7.802 | 5.697 | 5.162 | 4.827 | 5.699 | 3.828 | 3.188 | 2.379 | 0.508 | 0.558 | 0.462 | 0.454 | 0.893 | 0.412 | 0.375 | 0.37 | 0 | 0 | 0 | 1.101 | 0.317 | 0 | 0 | 0 | 0 | 0 | 0.317 | 0 | 0 |
| Cost of Revenue
| 0.325 | 0.331 | 0.334 | 0.279 | 0.616 | 0.653 | 0.704 | 0.77 | 0.724 | 0.726 | 0.747 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.325 | -0.331 | -0.334 | 0.107 | 3.146 | 2.18 | 2.25 | -6.237 | 3.167 | 5.55 | 4.72 | 7.802 | 5.697 | 5.162 | 4.827 | 5.699 | 3.828 | 3.188 | 2.379 | 0.508 | 0.558 | 0.462 | 0.454 | 0.893 | 0.412 | 0.375 | 0.37 | 0 | 0 | 0 | 1.101 | 0.317 | 0 | 0 | 0 | 0 | 0 | 0.317 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.277 | 0.836 | 0.77 | 0.762 | 1.141 | 0.814 | 0.884 | 0.863 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Reseach & Development Expenses
| 20.527 | 21.622 | 24.321 | 21.224 | 28.28 | 29.608 | 28.761 | 27.914 | 25.759 | 33.1 | 25.171 | 26.795 | 27.262 | 25.786 | 20.029 | 29.026 | 17.674 | 14.796 | 14.569 | 14.277 | 15.931 | 15.475 | 12.562 | 15.128 | 12.856 | 11.082 | 11.116 | 11.78 | 10.447 | 10.041 | 9.628 | 8.443 | 11.584 | 9.525 | 8.265 | 8.378 | 6.866 | 5.428 | 3.736 | 3.022 |
| General & Administrative Expenses
| 5.655 | 5.463 | 6.266 | 5.888 | 7.764 | 7.225 | 7.405 | 7.329 | 8.076 | 6.945 | 6.949 | 6.43 | 5.346 | 5.52 | 5.739 | 5.892 | 5.151 | 5.133 | 5.149 | 6.401 | 5.016 | 5.195 | 4.865 | 4.372 | 3.876 | 3.841 | 4.075 | 3.74 | 3.593 | 3.472 | 3.086 | 2.919 | 2.633 | 2.54 | 2.371 | 2.311 | 1.598 | 0.984 | 0.836 | 0.669 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.655 | 5.463 | 6.266 | 5.888 | 7.764 | 7.225 | 7.405 | 7.329 | 8.076 | 6.945 | 6.949 | 6.43 | 5.346 | 5.52 | 5.739 | 5.892 | 5.151 | 5.133 | 5.149 | 6.401 | 5.016 | 5.195 | 4.865 | 4.372 | 3.876 | 3.841 | 4.075 | 3.74 | 3.593 | 3.472 | 3.086 | 2.919 | 2.633 | 2.54 | 2.371 | 2.311 | 1.598 | 0.984 | 0.836 | 0.669 |
| Other Expenses
| 0 | -21.953 | 0 | 0.135 | 2.354 | 0 | 0 | 9.51 | -9.51 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.489 | -0.455 | 0.113 | 0.441 | 0.596 | 0.753 | 0.512 | 0.575 | 0.583 | 0.501 | 0.358 | 0.218 | 0.215 | 0.145 | 0.098 | 0.08 | 0.048 | 0.044 | 0.048 | 0 | 0 | -0.002 | 0.004 | 0 |
| Operating Expenses
| 26.182 | 27.085 | 30.587 | 27.112 | 38.398 | 36.833 | 36.166 | 35.243 | 33.835 | 40.045 | 32.12 | 33.225 | 32.608 | 31.306 | 25.768 | 34.918 | 22.825 | 19.929 | 19.718 | 20.678 | 20.947 | 20.67 | 17.427 | 19.5 | 16.732 | 14.923 | 15.191 | 15.52 | 14.04 | 13.513 | 12.714 | 11.362 | 14.217 | 12.065 | 10.636 | 10.689 | 8.464 | 6.412 | 4.572 | 3.693 |
| Operating Income
| -26.182 | -27.416 | -30.921 | -27.005 | -34.636 | -34 | -33.212 | -35.997 | -39.454 | -33.769 | -26.653 | -25.423 | -26.911 | -26.144 | -20.941 | -29.219 | -18.997 | -16.741 | -17.339 | -20.17 | -20.389 | -20.208 | -16.973 | -18.607 | -16.32 | -14.548 | -14.821 | -15.52 | -14.04 | -13.513 | -11.613 | -11.045 | -14.217 | -12.065 | -10.636 | -10.689 | -8.464 | -6.095 | -4.572 | -3.691 |
| Operating Income Ratio
| 0 | 0 | 0 | -69.961 | -9.207 | -12.001 | -11.243 | 6.584 | -10.14 | -5.381 | -4.875 | -3.259 | -4.724 | -5.065 | -4.338 | -5.127 | -4.963 | -5.251 | -7.288 | -39.705 | -36.539 | -43.74 | -37.385 | -20.837 | -39.612 | -38.795 | -40.057 | 0 | 0 | 0 | -10.548 | -34.842 | 0 | 0 | 0 | 0 | 0 | -19.227 | 0 | 0 |
| Total Other Income Expenses Net
| 19.786 | 4.089 | 27.213 | -37.379 | -8.191 | -3.105 | 9.423 | 31.223 | 9.201 | -0.712 | 1.507 | 2.565 | 1.836 | 4.611 | 7.67 | 0.455 | -0.489 | -0.455 | 0.113 | 0.441 | 0.596 | 0.753 | 0.512 | 0.575 | 0.583 | 0.501 | 0.358 | 0.218 | 0.215 | 0.145 | 0.098 | 0.08 | 0.048 | 0.044 | 0.048 | 0 | 0 | -0.002 | 0.004 | 0.002 |
| Income Before Tax
| -6.396 | -23.327 | -3.708 | -64.384 | -40.143 | -36.258 | -23.789 | -4.774 | -30.253 | -34.481 | -25.146 | -23.813 | -26.027 | -22.49 | -14.228 | -30.13 | -19.486 | -17.196 | -17.226 | -19.729 | -19.793 | -19.455 | -16.461 | -18.032 | -15.737 | -14.047 | -14.463 | -15.302 | -13.825 | -13.368 | -11.515 | -10.965 | -14.169 | -12.021 | -10.588 | -10.689 | -8.464 | -6.097 | -4.568 | -3.689 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -166.798 | -10.671 | -12.798 | -8.053 | 0.873 | -7.775 | -5.494 | -4.6 | -3.052 | -4.569 | -4.357 | -2.948 | -5.287 | -5.09 | -5.394 | -7.241 | -38.837 | -35.471 | -42.11 | -36.258 | -20.193 | -38.197 | -37.459 | -39.089 | 0 | 0 | 0 | -10.459 | -34.59 | 0 | 0 | 0 | 0 | 0 | -19.233 | 0 | 0 |
| Income Tax Expense
| -0.325 | 0 | 0.291 | 10.883 | -3.296 | 1.278 | -8.865 | -32.349 | -9.201 | 0.712 | -1.507 | 0.986 | 0.984 | 0.969 | 0.967 | 1.417 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.137 |
| Net Income
| -6.396 | -23.327 | -3.708 | -64.384 | -40.143 | -36.258 | -14.924 | 27.575 | -21.052 | -35.193 | -23.639 | -23.813 | -26.027 | -22.49 | -14.228 | -30.13 | -19.486 | -17.196 | -17.226 | -19.729 | -19.793 | -19.455 | -16.461 | -18.032 | -15.737 | -14.047 | -14.463 | -15.302 | -13.825 | -13.368 | -11.515 | -10.965 | -14.169 | -12.021 | -10.588 | -10.689 | -8.464 | -6.097 | -4.568 | -4.826 |
| Net Income Ratio
| 0 | 0 | 0 | -166.798 | -10.671 | -12.798 | -5.052 | -5.044 | -5.41 | -5.608 | -4.324 | -3.052 | -4.569 | -4.357 | -2.948 | -5.287 | -5.09 | -5.394 | -7.241 | -38.837 | -35.471 | -42.11 | -36.258 | -20.193 | -38.197 | -37.459 | -39.089 | 0 | 0 | 0 | -10.459 | -34.59 | 0 | 0 | 0 | 0 | 0 | -19.233 | 0 | 0 |
| EPS
| -0.16 | -0.59 | -0.095 | -2.18 | -1.43 | -1.3 | -0.54 | 0.99 | -2.24 | -5.51 | -3.75 | -3.78 | -4.14 | -3.6 | -2.32 | -4.91 | -4.26 | -3.76 | -3.92 | -4.6 | -4.66 | -4.67 | -4.87 | -5.35 | -4.68 | -4.27 | -4.77 | -5.81 | -5.26 | -5.23 | -4.92 | -4.69 | -6.44 | -47.08 | -4.65 | -5.96 | -33.15 | -23.88 | -2.55 | -29.78 |
| EPS Diluted
| -0.16 | -0.59 | -0.095 | -2.18 | -1.43 | -1.3 | -0.54 | 0.99 | -2.24 | -5.51 | -3.75 | -3.78 | -4.14 | -3.58 | -2.32 | -4.91 | -4.26 | -3.76 | -3.92 | -4.49 | -4.66 | -4.67 | -4.87 | -5.34 | -4.68 | -4.27 | -4.77 | -5.81 | -5.26 | -5.23 | -4.92 | -4.69 | -6.44 | -47.08 | -4.65 | -5.96 | -33.15 | -23.88 | -2.55 | -29.78 |
| EBITDA
| -26.182 | -27.085 | -30.587 | -26.726 | -34.636 | -31.225 | -30.799 | -33.634 | -38.338 | -32.931 | -25.871 | -24.619 | -26.114 | -25.383 | -20.2 | -28.4 | -18.23 | -15.984 | -16.596 | -19.272 | -19.746 | -19.559 | -16.441 | -18.175 | -15.912 | -14.172 | -14.433 | -15.52 | -13.649 | -13.132 | -11.248 | -10.707 | -13.902 | -11.749 | -10.332 | -10.46 | -8.275 | -5.985 | -4.498 | -3.62 |
| EBITDA Ratio
| 0 | 0 | 0 | -69.238 | -9.207 | -11.022 | -10.426 | 6.152 | -9.853 | -5.247 | -4.732 | -3.155 | -4.584 | -4.917 | -4.185 | -4.983 | -4.762 | -5.014 | -6.976 | -37.937 | -35.387 | -42.335 | -36.214 | -20.353 | -38.621 | -37.792 | -39.008 | 0 | 0 | 0 | -10.216 | -33.776 | 0 | 0 | 0 | 0 | 0 | -18.88 | 0 | 0 |